Adiponectin in heart failure.
Hubert MadoWioletta Szczurek-WasilewiczMariusz GąsiorBożena Szyguła-JurkiewiczPublished in: Future cardiology (2020)
The adipose tissue, apart from storing energy, plays a role of an endocrine organ. One of the most important adipokines secreted by adipose tissue is adiponectin, which is also produced by cardiomyocytes and connective tissue cells within the heart. Adiponectin is known for its beneficial effect on the metabolism and cardiovascular system and its low level is a factor of development of many cardiovascular diseases. Paradoxically, in the course of heart failure, adiponectin level gradually increases with the severity of the disease and higher adiponectin level is a factor of poor prognosis. As a result, there is a growing interest in adiponectin as a marker of heart failure progression and a predictor of prognosis in the course of this disease.
Keyphrases
- heart failure
- insulin resistance
- adipose tissue
- metabolic syndrome
- poor prognosis
- high fat diet
- long non coding rna
- cardiovascular disease
- left ventricular
- atrial fibrillation
- cardiac resynchronization therapy
- type diabetes
- skeletal muscle
- coronary artery disease
- oxidative stress
- signaling pathway
- cell proliferation
- cell cycle arrest
- endothelial cells